Financhill
Sell
42

PRGO Quote, Financials, Valuation and Earnings

Last price:
$27.10
Seasonality move :
2.28%
Day range:
$26.97 - $27.40
52-week range:
$23.14 - $30.93
Dividend yield:
4.13%
P/E ratio:
--
P/S ratio:
0.86x
P/B ratio:
0.85x
Volume:
1.1M
Avg. volume:
1.4M
1-year change:
-0.84%
Market cap:
$3.7B
Revenue:
$4.4B
EPS (TTM):
-$1.31

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
PRGO
Perrigo Co PLC
$1.1B $0.57 1.58% 5557.8% $34.60
ALKS
Alkermes PLC
$304.1M $0.24 -14.09% -21.11% $39.93
AMRN
Amarin Corp PLC
$50.7M -$0.40 -32.65% -- $8.00
AVDL
Avadel Pharmaceuticals PLC
$50.6M -$0.07 48.05% -76.67% $17.56
JAZZ
Jazz Pharmaceuticals PLC
$983.8M $4.66 3.11% -28.31% $184.76
MDT
Medtronic PLC
$8.8B $1.58 5.71% 53.43% $95.84
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
PRGO
Perrigo Co PLC
$27.10 $34.60 $3.7B -- $0.29 4.13% 0.86x
ALKS
Alkermes PLC
$29.90 $39.93 $4.9B 14.31x $0.00 0% 3.32x
AMRN
Amarin Corp PLC
$11.29 $8.00 $233.8M -- $0.00 0% 1.09x
AVDL
Avadel Pharmaceuticals PLC
$9.05 $17.56 $875.5M -- $0.00 0% 4.48x
JAZZ
Jazz Pharmaceuticals PLC
$107.01 $184.76 $6.6B 14.27x $0.00 0% 1.68x
MDT
Medtronic PLC
$81.24 $95.84 $104.1B 22.44x $0.70 3.45% 3.12x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
PRGO
Perrigo Co PLC
45.39% 0.039 94.29% 1.05x
ALKS
Alkermes PLC
-- 1.013 -- 2.72x
AMRN
Amarin Corp PLC
-- 0.064 -- 2.39x
AVDL
Avadel Pharmaceuticals PLC
-- -2.648 -- 2.12x
JAZZ
Jazz Pharmaceuticals PLC
56.25% 0.854 70.16% 2.64x
MDT
Medtronic PLC
37.26% 0.573 26.19% 1.20x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
PRGO
Perrigo Co PLC
$392.3M $79.4M -2.12% -4.01% 4.53% -$90M
ALKS
Alkermes PLC
$257.3M $13.8M 22.98% 25.91% 8.32% $88.7M
AMRN
Amarin Corp PLC
$25.1M -$16.8M -16.98% -16.98% -39.88% -$12.5M
AVDL
Avadel Pharmaceuticals PLC
$46.9M -$3M -35.57% -35.57% -4.96% -$8.2M
JAZZ
Jazz Pharmaceuticals PLC
$793.2M -$55.9M 4.93% 12.12% -6.25% $390.9M
MDT
Medtronic PLC
$5.8B $1.8B 6.12% 9.51% 16.08% $2.1B

Perrigo Co PLC vs. Competitors

  • Which has Higher Returns PRGO or ALKS?

    Alkermes PLC has a net margin of -0.61% compared to Perrigo Co PLC's net margin of 7.33%. Perrigo Co PLC's return on equity of -4.01% beat Alkermes PLC's return on equity of 25.91%.

    Company Gross Margin Earnings Per Share Invested Capital
    PRGO
    Perrigo Co PLC
    37.58% -$0.05 $8B
    ALKS
    Alkermes PLC
    83.95% $0.13 $1.5B
  • What do Analysts Say About PRGO or ALKS?

    Perrigo Co PLC has a consensus price target of $34.60, signalling upside risk potential of 27.68%. On the other hand Alkermes PLC has an analysts' consensus of $39.93 which suggests that it could grow by 33.56%. Given that Alkermes PLC has higher upside potential than Perrigo Co PLC, analysts believe Alkermes PLC is more attractive than Perrigo Co PLC.

    Company Buy Ratings Hold Ratings Sell Ratings
    PRGO
    Perrigo Co PLC
    1 3 0
    ALKS
    Alkermes PLC
    8 6 0
  • Is PRGO or ALKS More Risky?

    Perrigo Co PLC has a beta of 0.448, which suggesting that the stock is 55.199% less volatile than S&P 500. In comparison Alkermes PLC has a beta of 0.512, suggesting its less volatile than the S&P 500 by 48.82%.

  • Which is a Better Dividend Stock PRGO or ALKS?

    Perrigo Co PLC has a quarterly dividend of $0.29 per share corresponding to a yield of 4.13%. Alkermes PLC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Perrigo Co PLC pays -88.77% of its earnings as a dividend. Alkermes PLC pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios PRGO or ALKS?

    Perrigo Co PLC quarterly revenues are $1B, which are larger than Alkermes PLC quarterly revenues of $306.5M. Perrigo Co PLC's net income of -$6.4M is lower than Alkermes PLC's net income of $22.5M. Notably, Perrigo Co PLC's price-to-earnings ratio is -- while Alkermes PLC's PE ratio is 14.31x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Perrigo Co PLC is 0.86x versus 3.32x for Alkermes PLC. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    PRGO
    Perrigo Co PLC
    0.86x -- $1B -$6.4M
    ALKS
    Alkermes PLC
    3.32x 14.31x $306.5M $22.5M
  • Which has Higher Returns PRGO or AMRN?

    Amarin Corp PLC has a net margin of -0.61% compared to Perrigo Co PLC's net margin of -37.36%. Perrigo Co PLC's return on equity of -4.01% beat Amarin Corp PLC's return on equity of -16.98%.

    Company Gross Margin Earnings Per Share Invested Capital
    PRGO
    Perrigo Co PLC
    37.58% -$0.05 $8B
    AMRN
    Amarin Corp PLC
    59.81% -$0.80 $473.7M
  • What do Analysts Say About PRGO or AMRN?

    Perrigo Co PLC has a consensus price target of $34.60, signalling upside risk potential of 27.68%. On the other hand Amarin Corp PLC has an analysts' consensus of $8.00 which suggests that it could fall by -29.14%. Given that Perrigo Co PLC has higher upside potential than Amarin Corp PLC, analysts believe Perrigo Co PLC is more attractive than Amarin Corp PLC.

    Company Buy Ratings Hold Ratings Sell Ratings
    PRGO
    Perrigo Co PLC
    1 3 0
    AMRN
    Amarin Corp PLC
    0 1 0
  • Is PRGO or AMRN More Risky?

    Perrigo Co PLC has a beta of 0.448, which suggesting that the stock is 55.199% less volatile than S&P 500. In comparison Amarin Corp PLC has a beta of 0.660, suggesting its less volatile than the S&P 500 by 33.97%.

  • Which is a Better Dividend Stock PRGO or AMRN?

    Perrigo Co PLC has a quarterly dividend of $0.29 per share corresponding to a yield of 4.13%. Amarin Corp PLC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Perrigo Co PLC pays -88.77% of its earnings as a dividend. Amarin Corp PLC pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios PRGO or AMRN?

    Perrigo Co PLC quarterly revenues are $1B, which are larger than Amarin Corp PLC quarterly revenues of $42M. Perrigo Co PLC's net income of -$6.4M is higher than Amarin Corp PLC's net income of -$15.7M. Notably, Perrigo Co PLC's price-to-earnings ratio is -- while Amarin Corp PLC's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Perrigo Co PLC is 0.86x versus 1.09x for Amarin Corp PLC. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    PRGO
    Perrigo Co PLC
    0.86x -- $1B -$6.4M
    AMRN
    Amarin Corp PLC
    1.09x -- $42M -$15.7M
  • Which has Higher Returns PRGO or AVDL?

    Avadel Pharmaceuticals PLC has a net margin of -0.61% compared to Perrigo Co PLC's net margin of -9.37%. Perrigo Co PLC's return on equity of -4.01% beat Avadel Pharmaceuticals PLC's return on equity of -35.57%.

    Company Gross Margin Earnings Per Share Invested Capital
    PRGO
    Perrigo Co PLC
    37.58% -$0.05 $8B
    AVDL
    Avadel Pharmaceuticals PLC
    89.38% -$0.05 $74.1M
  • What do Analysts Say About PRGO or AVDL?

    Perrigo Co PLC has a consensus price target of $34.60, signalling upside risk potential of 27.68%. On the other hand Avadel Pharmaceuticals PLC has an analysts' consensus of $17.56 which suggests that it could grow by 93.98%. Given that Avadel Pharmaceuticals PLC has higher upside potential than Perrigo Co PLC, analysts believe Avadel Pharmaceuticals PLC is more attractive than Perrigo Co PLC.

    Company Buy Ratings Hold Ratings Sell Ratings
    PRGO
    Perrigo Co PLC
    1 3 0
    AVDL
    Avadel Pharmaceuticals PLC
    7 0 0
  • Is PRGO or AVDL More Risky?

    Perrigo Co PLC has a beta of 0.448, which suggesting that the stock is 55.199% less volatile than S&P 500. In comparison Avadel Pharmaceuticals PLC has a beta of 1.397, suggesting its more volatile than the S&P 500 by 39.743%.

  • Which is a Better Dividend Stock PRGO or AVDL?

    Perrigo Co PLC has a quarterly dividend of $0.29 per share corresponding to a yield of 4.13%. Avadel Pharmaceuticals PLC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Perrigo Co PLC pays -88.77% of its earnings as a dividend. Avadel Pharmaceuticals PLC pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios PRGO or AVDL?

    Perrigo Co PLC quarterly revenues are $1B, which are larger than Avadel Pharmaceuticals PLC quarterly revenues of $52.5M. Perrigo Co PLC's net income of -$6.4M is lower than Avadel Pharmaceuticals PLC's net income of -$4.9M. Notably, Perrigo Co PLC's price-to-earnings ratio is -- while Avadel Pharmaceuticals PLC's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Perrigo Co PLC is 0.86x versus 4.48x for Avadel Pharmaceuticals PLC. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    PRGO
    Perrigo Co PLC
    0.86x -- $1B -$6.4M
    AVDL
    Avadel Pharmaceuticals PLC
    4.48x -- $52.5M -$4.9M
  • Which has Higher Returns PRGO or JAZZ?

    Jazz Pharmaceuticals PLC has a net margin of -0.61% compared to Perrigo Co PLC's net margin of -10.31%. Perrigo Co PLC's return on equity of -4.01% beat Jazz Pharmaceuticals PLC's return on equity of 12.12%.

    Company Gross Margin Earnings Per Share Invested Capital
    PRGO
    Perrigo Co PLC
    37.58% -$0.05 $8B
    JAZZ
    Jazz Pharmaceuticals PLC
    88.35% -$1.52 $9.5B
  • What do Analysts Say About PRGO or JAZZ?

    Perrigo Co PLC has a consensus price target of $34.60, signalling upside risk potential of 27.68%. On the other hand Jazz Pharmaceuticals PLC has an analysts' consensus of $184.76 which suggests that it could grow by 72.66%. Given that Jazz Pharmaceuticals PLC has higher upside potential than Perrigo Co PLC, analysts believe Jazz Pharmaceuticals PLC is more attractive than Perrigo Co PLC.

    Company Buy Ratings Hold Ratings Sell Ratings
    PRGO
    Perrigo Co PLC
    1 3 0
    JAZZ
    Jazz Pharmaceuticals PLC
    10 2 0
  • Is PRGO or JAZZ More Risky?

    Perrigo Co PLC has a beta of 0.448, which suggesting that the stock is 55.199% less volatile than S&P 500. In comparison Jazz Pharmaceuticals PLC has a beta of 0.382, suggesting its less volatile than the S&P 500 by 61.836%.

  • Which is a Better Dividend Stock PRGO or JAZZ?

    Perrigo Co PLC has a quarterly dividend of $0.29 per share corresponding to a yield of 4.13%. Jazz Pharmaceuticals PLC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Perrigo Co PLC pays -88.77% of its earnings as a dividend. Jazz Pharmaceuticals PLC pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios PRGO or JAZZ?

    Perrigo Co PLC quarterly revenues are $1B, which are larger than Jazz Pharmaceuticals PLC quarterly revenues of $897.8M. Perrigo Co PLC's net income of -$6.4M is higher than Jazz Pharmaceuticals PLC's net income of -$92.5M. Notably, Perrigo Co PLC's price-to-earnings ratio is -- while Jazz Pharmaceuticals PLC's PE ratio is 14.27x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Perrigo Co PLC is 0.86x versus 1.68x for Jazz Pharmaceuticals PLC. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    PRGO
    Perrigo Co PLC
    0.86x -- $1B -$6.4M
    JAZZ
    Jazz Pharmaceuticals PLC
    1.68x 14.27x $897.8M -$92.5M
  • Which has Higher Returns PRGO or MDT?

    Medtronic PLC has a net margin of -0.61% compared to Perrigo Co PLC's net margin of 11.84%. Perrigo Co PLC's return on equity of -4.01% beat Medtronic PLC's return on equity of 9.51%.

    Company Gross Margin Earnings Per Share Invested Capital
    PRGO
    Perrigo Co PLC
    37.58% -$0.05 $8B
    MDT
    Medtronic PLC
    64.75% $0.82 $76.8B
  • What do Analysts Say About PRGO or MDT?

    Perrigo Co PLC has a consensus price target of $34.60, signalling upside risk potential of 27.68%. On the other hand Medtronic PLC has an analysts' consensus of $95.84 which suggests that it could grow by 17.97%. Given that Perrigo Co PLC has higher upside potential than Medtronic PLC, analysts believe Perrigo Co PLC is more attractive than Medtronic PLC.

    Company Buy Ratings Hold Ratings Sell Ratings
    PRGO
    Perrigo Co PLC
    1 3 0
    MDT
    Medtronic PLC
    12 13 1
  • Is PRGO or MDT More Risky?

    Perrigo Co PLC has a beta of 0.448, which suggesting that the stock is 55.199% less volatile than S&P 500. In comparison Medtronic PLC has a beta of 0.811, suggesting its less volatile than the S&P 500 by 18.855%.

  • Which is a Better Dividend Stock PRGO or MDT?

    Perrigo Co PLC has a quarterly dividend of $0.29 per share corresponding to a yield of 4.13%. Medtronic PLC offers a yield of 3.45% to investors and pays a quarterly dividend of $0.70 per share. Perrigo Co PLC pays -88.77% of its earnings as a dividend. Medtronic PLC pays out 76.98% of its earnings as a dividend. Medtronic PLC's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios PRGO or MDT?

    Perrigo Co PLC quarterly revenues are $1B, which are smaller than Medtronic PLC quarterly revenues of $8.9B. Perrigo Co PLC's net income of -$6.4M is lower than Medtronic PLC's net income of $1.1B. Notably, Perrigo Co PLC's price-to-earnings ratio is -- while Medtronic PLC's PE ratio is 22.44x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Perrigo Co PLC is 0.86x versus 3.12x for Medtronic PLC. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    PRGO
    Perrigo Co PLC
    0.86x -- $1B -$6.4M
    MDT
    Medtronic PLC
    3.12x 22.44x $8.9B $1.1B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Tesla Stock Overvalued or a Buy for the Next Decade?
Is Tesla Stock Overvalued or a Buy for the Next Decade?

Shares of EV major Tesla (NASDAQ:TSLA) have experienced extreme volatility…

Is Apple Stock Undervalued or Overvalued?
Is Apple Stock Undervalued or Overvalued?

For many years, Apple (NASDAQ:AAPL) was just about the perfect…

Where Will Palo Alto Networks Stock Be in 5 Years?
Where Will Palo Alto Networks Stock Be in 5 Years?

You know those companies that just refuse to slow down…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
68
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
70
AGFY alert for May 29

Agrify [AGFY] is up 18.95% over the past day.

Buy
100
BOX alert for May 29

Box [BOX] is up 17.27% over the past day.

Sell
22
OKTA alert for May 29

Okta [OKTA] is down 16.14% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock